Worth your time

In a decision made through the lens of the 2020 election, President Trump overruled health secretary Alex Azar in deciding to heavily restrict use of federal funds for research using fetal tissue, the Washington Post reports. — Lev Facher
 
Stem cell clinics are co-opting the NIH's clinical-trials registry to market unproven therapies, according to critics. As STAT writes, "to let such dubious vendors post on a federal website, the critics say, is to lend them an air of legitimacy they don’t deserve."

STAT also sat down with Jeremy Levin, the incoming board chairman at the industry group BIO, to talk about his plans for the group’s advocacy on drug pricing — and his penchant for going off script. — Erin Mershon
 
The New York Times has a fascinating report digging into how drug makers are undercutting warnings from global health officials about the use of antibiotics in livestock. — Nicholas Florko